Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsInterest & Investment IncomeNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to $696.9 million.

  • Roivant Sciences' Shares Outstanding (Weighted Average) fell 471.18% to $696.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $696.9 million, marking a year-over-year decrease of 471.18%. This contributed to the annual value of $725.4 million for FY2025, which is 738.63% down from last year.
  • Latest data reveals that Roivant Sciences reported Shares Outstanding (Weighted Average) of $696.9 million as of Q4 2025, which was down 471.18% from $680.9 million recorded in Q3 2025.
  • In the past 5 years, Roivant Sciences' Shares Outstanding (Weighted Average) ranged from a high of $800.6 million in Q4 2023 and a low of $630.0 million during Q1 2021
  • Over the past 5 years, Roivant Sciences' median Shares Outstanding (Weighted Average) value was $706.3 million (recorded in 2022), while the average stood at $710.4 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 20242.88% in 2021, then plummeted by 865.23% in 2024.
  • Roivant Sciences' Shares Outstanding (Weighted Average) (Quarter) stood at $686.6 million in 2021, then increased by 3.89% to $713.3 million in 2022, then grew by 12.23% to $800.6 million in 2023, then fell by 8.65% to $731.3 million in 2024, then dropped by 4.71% to $696.9 million in 2025.
  • Its last three reported values are $696.9 million in Q4 2025, $680.9 million for Q3 2025, and $680.3 million during Q2 2025.